OPNT logo

Opiant Pharmaceuticals (OPNT) Net Income

Annual Net Income

$3.01 M
+$4.87 M+261.64%

December 31, 2021

Summary

Performance

1-Year Change

+261.64%

3-Year Change

+114.2%

5-Year Change

+118.12%

15-Year Change

+118.12%

OPNT Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.59 M
OPNT annual net profit is currently -74.05% below its historical high of $11.59 million

3-Year Low

$3.01 M
OPNT annual net profit is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
OPNT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
OPNT next annual earnings announcement has not yet been scheduled

OtherOPNTprofitabilitymetrics:

Annual Net Margin

7.39%
OPNT annual net profit margin is 7.39%

Annual Revenue

$40.73 M
OPNT annual revenue is $40.73 million

Annual Gross Profit

$31.66 M
OPNT annual gross profit is $31.66 million

Annual EPS

$0.51
OPNT annual earnings per share is $0.51

Quarterly Net Income

-$9.92 M
+$1.82 M+15.51%

September 30, 2022

Summary

Performance

3-Month Change

+15.51%

1-Year Change

-390.21%

3-Year Change

-192.83%

5-Year Change

-76.04%

OPNT Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.68 M
OPNT quarterly net profit is currently -192.83% below its historical high of $10.68 million

3-Year Low

-$12.19 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
OPNT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
OPNT next earnings announcement has not yet been scheduled

OtherOPNTprofitabilitymetrics:

Quarterly Net Margin

-
OPNT quarterly net profit margin value is unknown

Quarterly Revenue

-
OPNT quarterly revenue value is unknown

Quarterly Gross Profit

$0.00
OPNT quarterly gross profit is $0.00

Quarterly EPS

-$1.93
OPNT quarterly earnings per share is -$1.93

TTM Net Income

-$33.09 M
-$13.33 M-67.50%

September 30, 2022

Summary

Performance

3-Month Change

-67.5%

1-Year Change

-2206.35%

3-Year Change

-385.42%

5-Year Change

-385.42%

OPNT TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.64 M
OPNT TTM net profit is currently -384.16% below its historical high of $11.64 million

3-Year Low

-$33.09 M
OPNT TTM net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
OPNT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
OPNT next earnings announcement has not yet been scheduled

OtherOPNTprofitabilitymetrics:

Annual Net Margin

7.39%
OPNT annual net profit margin is 7.39%

TTM Revenue

-
OPNT TTM revenue value is unknown

TTM Gross Profit

$13.69 M
OPNT TTM gross profit is $13.69 million

TTM EPS

-$6.57
OPNT TTM earnings per share is -$6.57

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$3.01 M
OPNT annual net profit is $3.01 million

Annual Revenue

$40.73 M
OPNT annual revenue is $40.73 million

Annual Cost Of Goods Sold

$9.07 M
OPNT annual cost of goods sold is $9.07 million

Annual Operating Expenses

$26.50 M
OPNT annual total operating expenses is $26.50 million

Annual Interest Expense

$2.13 M
OPNT annual interest expense is $2.13 million

Annual Income Tax

$24.30 K
OPNT annual income tax is $24.30 thousand

OPNT Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+261.6%-390.2%-2206.3%
3 y3 years+114.2%-192.8%-385.4%
5 y5 years+118.1%-76.0%-385.4%

OPNT Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-1418.2%+22.9%-1199.7%at low
5 y5-year-74.0%-161.9%-390.2%+22.9%-384.2%at low
alltimeall time-74.0%-804.4%-192.8%+22.9%-384.2%at low

Opiant Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2022
-
-$9.92 M(-15.5%)
-$33.09 M(+67.5%)
Jun 2022
-
-$11.74 M(-3.7%)
-$19.75 M(+211.8%)
Mar 2022
-
-$12.19 M(-1720.1%)
-$6.33 M(-310.5%)
Dec 2021
$3.01 M(-261.6%)
$752.30 K(-78.0%)
$3.01 M(+91.5%)
Sep 2021
-
$3.42 M(+103.0%)
$1.57 M(-240.1%)
Jun 2021
-
$1.68 M(-159.2%)
-$1.12 M(-62.9%)
Mar 2021
-
-$2.84 M(+314.8%)
-$3.02 M(+62.3%)
Dec 2020
-$1.86 M(-116.1%)
-$685.60 K(-194.6%)
-$1.86 M(+1623.5%)
Sep 2020
-
$725.00 K(-435.3%)
-$108.00 K(-101.1%)
Jun 2020
-
-$216.20 K(-87.2%)
$9.85 M(-15.4%)
Mar 2020
-
-$1.68 M(-257.8%)
$11.64 M(+0.4%)
Dec 2019
$11.59 M(-154.7%)
$1.07 M(-90.0%)
$11.59 M(+1073.4%)
Sep 2019
-
$10.68 M(+576.9%)
$988.00 K(-109.3%)
Jun 2019
-
$1.58 M(-190.9%)
-$10.61 M(-21.9%)
Mar 2019
-
-$1.74 M(-81.8%)
-$13.59 M(-35.9%)
Dec 2018
-$21.20 M(-1636.6%)
-$9.54 M(+938.9%)
-$21.20 M(+81.8%)
Sep 2018
-
-$918.00 K(-34.3%)
-$11.66 M(-28.8%)
Jun 2018
-
-$1.40 M(-85.0%)
-$16.37 M(+6.9%)
Mar 2018
-
-$9.34 M(+65.9%)
-$15.32 M(-1089.2%)
Dec 2017
$1.38 M(-79.0%)
-
-
Oct 2017
-
-$5.63 M(+1562.1%)
$1.55 M(-76.5%)
Jul 2017
$6.58 M(-184.2%)
-$338.90 K(-89.2%)
$6.58 M(+12.9%)
Apr 2017
-
-$3.13 M(-129.4%)
$5.83 M(-37.8%)
Jan 2017
-
$10.65 M(-1872.0%)
$9.37 M(+247.9%)
Oct 2016
-
-$601.00 K(-44.9%)
$2.69 M(-134.5%)
Jul 2016
-$7.81 M(+11.0%)
-$1.09 M(-362.1%)
-$7.81 M(-6.5%)
Apr 2016
-
$416.10 K(-89.5%)
-$8.36 M(-21.3%)
Jan 2016
-
$3.97 M(-135.7%)
-$10.63 M(-38.8%)
Oct 2015
-
-$11.11 M(+579.0%)
-$17.37 M(+146.8%)
Jul 2015
-$7.04 M(-38.7%)
-$1.64 M(-11.6%)
-$7.04 M(-26.4%)
Apr 2015
-
-$1.85 M(-33.3%)
-$9.56 M(+15.7%)
Jan 2015
-
-$2.78 M(+258.0%)
-$8.26 M(-21.6%)
Oct 2014
-
-$775.30 K(-81.4%)
-$10.54 M(-8.2%)
DateAnnualQuarterlyTTM
Jul 2014
-$11.48 M(+25.1%)
-$4.16 M(+650.6%)
-$11.48 M(+33.2%)
Apr 2014
-
-$554.20 K(-89.0%)
-$8.62 M(-2.3%)
Jan 2014
-
-$5.06 M(+195.0%)
-$8.82 M(-12.3%)
Oct 2013
-
-$1.71 M(+31.9%)
-$10.06 M(+9.3%)
Jul 2013
-$9.18 M(-26.1%)
-$1.30 M(+71.7%)
-$9.20 M(-3.8%)
Apr 2013
-
-$756.80 K(-88.0%)
-$9.57 M(-7.0%)
Jan 2013
-
-$6.29 M(+633.7%)
-$10.28 M(+20.0%)
Oct 2012
-
-$857.30 K(-48.5%)
-$8.57 M(-31.1%)
Jul 2012
-$12.42 M(+31.6%)
-$1.66 M(+13.0%)
-$12.43 M(-8.1%)
Apr 2012
-
-$1.47 M(-67.8%)
-$13.53 M(-22.5%)
Jan 2012
-
-$4.58 M(-3.0%)
-$17.46 M(+25.8%)
Oct 2011
-
-$4.72 M(+71.0%)
-$13.87 M(+47.0%)
Jul 2011
-$9.44 M(+367.9%)
-$2.76 M(-48.9%)
-$9.44 M(+31.8%)
Apr 2011
-
-$5.40 M(+442.8%)
-$7.16 M(+261.9%)
Jan 2011
-
-$994.70 K(+253.0%)
-$1.98 M(-11.0%)
Oct 2010
-
-$281.80 K(-41.8%)
-$2.22 M(+10.2%)
Jul 2010
-$2.02 M(-7201.1%)
-$484.40 K(+122.8%)
-$2.02 M(+35.3%)
Apr 2010
-
-$217.40 K(-82.5%)
-$1.49 M(+16.7%)
Jan 2010
-
-$1.24 M(+1525.7%)
-$1.28 M(+2920.8%)
Oct 2009
-
-$76.20 K(-283.6%)
-$42.30 K(-248.4%)
Jul 2009
$28.40 K(-258.7%)
$41.50 K(-1065.1%)
$28.50 K(-214.0%)
Apr 2009
-
-$4300.00(+30.3%)
-$25.00 K(+10.6%)
Jan 2009
-
-$3300.00(-38.9%)
-$22.60 K(0.0%)
Oct 2008
-
-$5400.00(-55.0%)
-$22.60 K(+26.3%)
Jul 2008
-$17.90 K(-46.7%)
-$12.00 K(+531.6%)
-$17.90 K(-0.6%)
Apr 2008
-
-$1900.00(-42.4%)
-$18.00 K(-15.1%)
Jan 2008
-
-$3300.00(+371.4%)
-$21.20 K(+14.6%)
Oct 2007
-
-$700.00(-94.2%)
-$18.50 K(-29.4%)
Jul 2007
-$33.60 K
-$12.10 K(+137.3%)
-$26.20 K(+85.8%)
Apr 2007
-
-$5100.00(+750.0%)
-$14.10 K(+48.4%)
Jan 2007
-
-$600.00(-92.9%)
-$9500.00(+6.7%)
Oct 2006
-
-$8400.00(+1580.0%)
-$8900.00(+1680.0%)
Apr 2006
-
-$500.00(<-9900.0%)
-$500.00(<-9900.0%)
Jan 2006
-
$0.00
$0.00

FAQ

  • What is Opiant Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals annual net income year-on-year change?
  • What is Opiant Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals quarterly net income year-on-year change?
  • What is Opiant Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals TTM net income year-on-year change?

What is Opiant Pharmaceuticals annual net profit?

The current annual net income of OPNT is $3.01 M

What is the all time high annual net income for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high annual net profit is $11.59 M

What is Opiant Pharmaceuticals annual net income year-on-year change?

Over the past year, OPNT annual net profit has changed by +$4.87 M (+261.64%)

What is Opiant Pharmaceuticals quarterly net profit?

The current quarterly net income of OPNT is -$9.92 M

What is the all time high quarterly net income for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high quarterly net profit is $10.68 M

What is Opiant Pharmaceuticals quarterly net income year-on-year change?

Over the past year, OPNT quarterly net profit has changed by -$13.33 M (-390.21%)

What is Opiant Pharmaceuticals TTM net profit?

The current TTM net income of OPNT is -$33.09 M

What is the all time high TTM net income for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high TTM net profit is $11.64 M

What is Opiant Pharmaceuticals TTM net income year-on-year change?

Over the past year, OPNT TTM net profit has changed by -$34.66 M (-2206.35%)